A possible alternative to antibacterial therapy in the treatment of acute rhinosinusitis

High incidence of acute rhinosinusitis in a population remains one of the topical issues in practical otolaryngology. Statistical data show an increasing trend towards transition of acute rhinosinusitis in patients into chronic rhinosinusitis. According to literary sources, the emergence of bacterial resistance to antibiotics is as a rule the major reason of protracted course of the disease. Unreasonable antibiotics prescription, irrational use and uncontrolled intake result in the rapid development of antibiotic resistance. In this context, the use of herbal medicines having not only antibacterial, but also mucolytic, fungicidal, antioxidant effects in the complex therapy is a modern solution for disease management. Respero Myrtol, a standardized myrtol-based medicine, has taken its rightful place in the therapy. This article is aimed to investigate the possibilities of the effective use of medicine containing standardized myrtol as its main ingredient in the treatment of acute rhinosinusitis (based on the review of literature). Research materials included scientific articles on aspects of acute rhinosinusitis in otorhinolaryngology practice that were published in domestic specialized periodicals of eLIBRARY and scientific databases Scopus, Web of Science, Medline from 2014 to 2024. The published literature was analysed using the cause-and-effect technique. A clinical example was dis-cussed. With regard to the analysis of scientific literature, a brief overview of the epidemiology, etiology, predisposing factors for the development, diagnosis and treatment of acute rhinosinusitis was provided. The article addresses relevant socio-economic issues related to acute rhinosinusitis, the problem of antibiotic resistance. The issues of improving acute rhinosinusitis treatments using a standardized myrtol medicine in complex therapy as an alternative to antibiotic therapy were brought to attention. As a result, the authors concluded that the use of Respero Myrtol contributes to the rapid relief of clinical symptoms of acute rhinosinusitis, improves the patient’s quality of life, and can be advised as an alternative to antibiotic therapy in uncomplicated course of the disease.

1. Карнеева ОВ, Гуров АВ, Карпова ЕП, Тулупов ДА, Рязанцев СВ, Гаращенко ТИ. Острый синусит: клинические рекомендации. М.; 2021. Режим доступа: https://cr.minzdrav.gov.ru/schema/313_2.

2. Лопатин АС (ред.). Острый риносинусит: клинические рекомендации. М.; 2017. 36 с. Режим доступа: http://rhinology.ru/wp-content/uploads/2017/09/Острый-риносинусит-21.09.pdf.

3. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. https://doi.org/10.4193/Rhin20.600.

4. Krivopalov AA, Ryazantsev SV, Erin SA, Zakharova GP, Shabalin VV, Shapkina PA. The question about the topical antibiotic therapy of acute rhinosinusitis. Vestnik Oto- Rino- Laringologii. 2019;84(2):50–56. (In Russ.) https://doi.org/10.17116/otorino20198402150.

5. Korkmazov MYu, Kazachkov EL, Lengina MA, Dubinets ID, Korkmazov AM. Cause-effect factors of rhinosinusitis poliposa development. Russian Rhinology. 2023;31(2):124–130. (In Russ.) https://doi.org/10.17116/rosrino202331021124.

6. Shchelkunov DS, Krishtopova MA, Kulikov AV, Semenov VM. Acute Rhinosinusitis: Overuse of Diagnostic Tools and Treatment. Otorhinolaryngology. Eastern Europe. 2021;11(4):460–469. (In Russ.) https://doi.org/10.34883/PI.2021.11.4.021.

7. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(S2):S1–S39. https://doi.org/10.1177/0194599815572097.

8. Krivopalov AA. Rhinosinusitis: classification, epidemiology, etiology and treatment. Meditsinskiy Sovet . 2016;(6):22–25. (In Russ.) https://doi.org/10.21518/2079-701X-2016-6-22-25.

9. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2012 (EP3OS). Rhinology. 2012;50(23):1–299. Available at: https://pubmed.ncbi.nlm.nih.gov/17708455.

10. Krivopalov AA. Rhinosinusitis: Definitions, classifications, etiology and epidemiology (А review of literature). Russian Rhinology. 2016;24(2):39–45. (In Russ.) https://doi.org/10.17116/rosrino201624239-45.

11. Nacharov PV, Krivopalov AA, Khamgushkeeva NN. Bacteriophages in therapy of bacterial rhinosinusitis. Rossiiskaya Otorinolaringologiya. 2022;22(3):69–74. (In Russ.) https://doi.org/10.18692/1810-4800-2023-3-69-74.

12. Gisinger OA, Korkmazov AM, Korkmazov MYu. The state of antimicrobial protection factors of nasal secretion in patients operated on the curvature of the nasal septum in the early postoperative period. Russian Journal of Immunology. 2017;20(2):117–119. (In Russ.) Available at: https://rusimmun.ru/jour/article/view/597/485.

13. Korkmazov MYu, Dubinets ID, Lengina MA, Korkmazov AM, Kornova NV, Ryabenko YuI. Distinct indexes of immunological reactivity in surgical alteration of orl organs. Russian Journal of Immunology. 2022;25(2):201–206. (In Russ.) https://rusimmun.ru/jour/article/view/1121/957/ru_RU.

14. Korkmazov AM, Korkmazov MYu. Methods of correction of the functional infringements of phagocytes and local manifestations of oxidative stress in the multiple shell of the nose region with use of ultrasound cavitation. Russian Journal of Immunology. 2018;21(3):325–328. (In Russ.) https://doi.org/10.31857/S102872210002404-9.

15. Dubinets ID, Korkmazov MYu, Sinitskii AI, Danshova EI, Skirpichnikov IN, Mokina MV. Local and systemic oxidative stress in chronic suppurative otitis media. Meditsinskiy Sovet. 2021;(18):148–156. (In Russ.) https://doi.org/10.21518/2079-701X-2021-18-148-156.

16. Arcimowicz M. Acute sinusitis in daily clinical practice. Otolaryngol Pol. 2021;75(4):40–50. https://doi.org/10.5604/01.3001.0015.2378.

17. Bodzhokov AA, Polyakov DP, Degtyareva DV. Modern methods of treatment of chronic rhinosinusitis in children. Rossiiskaya Otorinolaringologiya. 2023;22(1):74–78 (In Russ.) https://doi.org/10.18692/1810-4800-2023-1-74-78.

18. Korkmazov MYu, Kornova NV, Lengina MA, Smirnov AA, Korkmazov AM, Dubinets ID. Effective antibiotic therapy for community-a cquired otorhinolaryngological respiratory infection (clinical description). Meditsinskiy Sovet. 2022;16(20):73–81. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-73-81.

19. Yanov YuK, Krivopalov AA, Tuzikov NA, Schneider NA, Nasyrova RF, Shcherbuk AYu. The possibilities and prospects of the use of automated techniques of medical care quality assessment in otorhinolaryngology. Rossiiskaya Otorinolaringologiya. 2019;18(2):85–94. (In Russ.) https://doi.org/10.18692/1810-4800-2019-2-85-94.

20. Lopatin AS, Varvyanskaya AV. Acute and chronic rhinosinusitis: principles of therapy. Meditsinskiy Sovet. 2014;(3):24–27. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/522.

21. Yeremenko YuE, Sidelova SI, Shestakova EV, Titov LP, Talankina AS, Nosova ES. The problem of antibiotic resistance in patients with acute and chronic rhinosinusitis. Otorhinolaryngology. Eastern Europe. 2020;10(2):141–151. (In Russ.) https://doi.org/10.34883/PI.2020.2.2.010.

22. Korkmazov MYu, Zyryanova KS, Beloshangin AS. Evaluation of the clinical efficacy of a phytotherapeutic drug in the treatment and prevention of relapses of acute rhinosinusitis in children in Chelyabinsk. Meditsinskiy Sovet. 2016;(7):90–93. (In Russ.) https://doi.org/10.21518/2079701X-2016-07-90-93.

23. Korkmazov MYu, Lengina MA, Korkmazov АM, Kornova NV, Beloshangin АS. Treatment and prevention of various forms of laryngitis on the background of acute respiratory infections. Meditsinskiy Sovet. 2022;16(8):79–87. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-8-79-87.

24. Svistushkin VM, Nikiforova GN, Kiselev AB, Chaukina VA, Shevchik EA, Kochetkov PA. Therapy of acute rhinosinusitis in patients with allergic rhinitis: possibilities for implementing advanced control of inflammation. Meditsinskiy Sovet. 2023;18(19):125–135. (In Russ.) https://doi.org/10.21518/ms2023-35.

25. Ryazantsev SV, Konoplev OI, Krivopalov AA, Shatalov VA. Anti-inflammatory therapy of acute rhinosinusitis using ketoprofen lysine salt. Meditsinskiy Sovet. 2015;(15):8–11. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/375.

26. Yanov YuK, Krivopalov AA, Korneyenkov AA, Shcherbuk YuA, Artyushkin SA, Vakhrushev SG. The modern epidemiological characteristics of oto- and rhinosinusogenic intracranial complications. Vestnik Oto-Rino-Laringologii. 2015;80(6):32–37. (In Russ.) https://doi.org/10.17116/otorino201580632-37.

27. Lopatin AS. Acute rhinosinusitis in EPOS 2020 and updated guidelines of the Russian Rhinologic Society. Pharmacology & Pharmacotherapy. 2022;(S1):30–36. (In Russ.) https://doi.org/10.46393/27132129_2022_S_30.

28. Krivopalov AA, Ryazantsev SV, Shatalov VA, Shervashidze SV. Acute rhinitis: new therapeutic possibilities. Meditsinskiy Sovet. 2017;(8):18–23. (In Russ.) https://doi.org/10.21518/2079-701X-2017-8-18-23.

29. Savlevich EL, Pelishenko TG, Kozlov VS, Koryagin FN, Koryagina TS. Perioperative management of patients with operated nasal cavity and paranasal sinuses. Rossiiskaya Otorinolaringologiya. 2021;20(4):102–109. (In Russ.) https://doi.org/10.18692/1810-4800-2021-4-102-109.

30. Кривопалов АА, Щербук АЮ, Щербук ЮА, Янов ЮК (ред.). Внутричерепные гнойно-воспалительные осложнения острых и хронических заболеваний уха, носа и околоносовых пазух. СПб.; 2018. 234 с.

31. Ryazantsev SV, Krivopalov AA, Eremin SA, Zakharova GP, Shabalin VV, Shapkina PA. Topical antibacterial therapy of acute rhinosinusitis. RMJ. 2020;(4):2–7. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Topicheskaya_antibakterialynaya_terapiya_ostrogo_rinosinusita/?utm_source=google.com&utm_medium=organic&utm_campaign=google.com&utm_referrer=google.com.

32. Kochetkov PA, Fatyanova EI. Acute rhinosinusitis: actual approaches to diagnosis and treatment. Meditsinskiy Sovet. 2017;(8):130–136. (In Russ.) https://doi.org/10.21518/2079-701X-2017-8-130-136.

33. Svistushkin VM, Shevchik EA. Acute rhinosinusitis – a modern view of the problem. RMJ. 2014;(9):643–646. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Ostryy_rinosinusit__sovremennyy_vzglyad_na_problemu.

34. Petrova LG. Modern principles of treatment of acute rhinosinusitis. Meditsinskie Novosti. 2021;(2):67–70. (In Russ.) Available at: https://cyberleninka.ru/ article/n/sovremennye-printsipy-lecheniya-ostrogo-rinosinusita.

35. DeBoer DL, Kwon E. Acute Sinusitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://pubmed.ncbi.nlm.nih.gov/31613481.

36. Chitsuthipakorn W, Kanjanawasee D, Hoang MP, Seresirikachorn K, Snidvongs K. Optimal Device and Regimen of Nasal Saline Treatment for Sinonasal Diseases: Systematic Review. OTO Open. 2022;6(2):2473974X221105277. https://doi.org/10.1177/2473974X221105277.

37. Korkmazov MYu, Lengina MA, Korkmazov АM, Kornova NV, Beloshangin АS. Treatment and prevention of various forms of laryngitis on the background of acute respiratory infections. Meditsinskiy Sovet. 2022;16(8):79–87. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-8-79-87.

38. Jaume F, Valls-M ateus M, Mullol J. Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020. Curr Allergy Asthma Rep. 2020;20(7):28. https://doi.org/10.1007/s11882-020-00917-5.

39. Mahdavinia M, Keshavarzian A, Tobin MC, Landay AL, Schleimer RP. A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). Clin Exp Allergy. 2016;46(1):21–41. https://doi.org/10.1111/cea.12666.

40. Svistushkin VM, Nikiforova GN, Lobacheva VV. Rational Antibiotic Therapy in Patients with Bacterial Rhinosinusitis. Doktor. Ru. 2020;19(11):42–45. (In Russ.) https://doi.org/10.31550/1727-2378-2020-19-11-42-45.

41. Derbeneva ML, Guseva AL. Acute rhinosinusitis: diagnosis and treatment. Consilium Medicum. 2018;20(3):58–60. (In Russ.) https://doi.org/10.26442/ 2075-1753_20.3.58-60.

42. Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. All Asth Clin Immun. 2011;7(1):2. https://doi.org/10.1186/1710-1492-7-2.

43. Eje MA, Ovchinnikov AYu, Khon EM. Current treatment regimens for patients with acute bacterial rhinosinusitis. Consilium Medicum. 2016;18(11):63–66. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/94587.

44. Tan KS, Yan Y, Ong HH, Chow VTK, Shi L, Wang DY. Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):24. https://doi.org/10.1007/s11882-017-0693-2.

45. Korkmazov MYu, Angelovich MS, Lengina MA, Belousov SYu. Clinical case of angiosarcoma of ethmoidal labyrinth and frontal sinus, issues of morphological verification of diagnosis. Vestnik Oto-Rino-Laringologii. 2022;87(4):102–106. (In Russ.) https://doi.org/10.17116/otorino202287041102.

46. Korkmazov MYu, Angelovich MS, Lengina MA, Yastremsky AP. Fifteen years of experience in plastic liquor fistulas using high-intensity laser radiation. Meditsinskiy Sovet. 2021;16(18):192–201. (In Russ.) https://doi.org/10.21518/2079-701X-2021-18-192-201.

47. Nosulya EV, Kim IA, Luchsheva YuV, Ogorodnikov DS. Acute rhinosinusitis: treatment with a focus on key elements of pathogenesis. Russian Rhinology. 2023;31(3):212–218. (In Russ.) https://doi.org/10.17116/rosrino202331031212.

48. Visel AA, Visel IY, Gizatullina ED. Complex approach to therapy of acute and chronic dieases of respiratory organs. Meditsinskiy Sovet. 2017;(18):102–106. (In Russ.) https://doi.org/10.21518/2079-701X-2017-18-102-106.

49. Ryazantsev SV, Altushkin SA, Budkovaya MA. Place of mukoactive therapy of rinosinusitis in international and russian guidelines. Meditsinskiy Sovet. 2017;(16):24–27. (In Russ.) https://doi.org/10.21518/2079-701X-2017-16-24-27.

50. Karpova EP, Tulupov DA. The possibilities of phytotherapeutic drugs based on myrtol standardized in the treatment of rhinosinusitis. RMJ. 2014;(26):1912–1915. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Vozmoghnosti_fitoterapevticheskih_lekarstvennyh_sredstv_na_osnove_mirtola_standartizirovannogo_v_terapii_rinosinusita.

51. Gromakov VA. Mirtol standardized in treatment of acute rhinosinusitis. Vestnik Oto- Rino- Laringologii. 2012;77(1):57–58. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/1/030042-46682012117.

52. Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis – results of a double-blind, randomized multicenter study compared with placebo. Laryngorhinootologie. 1997;76(1):23–27. https://doi.org/10.1055/s-2007-997381.